BioMarin Pharmaceutical Inc

Type: Company
Name: BioMarin Pharmaceutical Inc
Nationality: United States
Web Address: http://www.bmrn.com/
First reported 6 hours ago - Updated 6 hours ago - 1 reports
Aegerion Pharmaceuticals Inc
Aegerion Pharmaceuticals Inc

The Best- And Worst- Performing Biotech Stocks, May 10 To May 17

These are the best and worst-performing medical and biotech stocks from May 10 to May 17, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations ... [Published Forbes.com - 6 hours ago]
First reported May 18 2013 - Updated May 18 2013 - 1 reports

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: SPIEGELMAN DANIEL K

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: SPIEGELMAN DANIEL K ... [Published Street Insider - May 18 2013]
First reported May 18 2013 - Updated May 18 2013 - 1 reports

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: MEIER RICHARD A

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: MEIER RICHARD A ... [Published Street Insider - May 18 2013]
First reported May 18 2013 - Updated May 18 2013 - 1 reports

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: LAWLIS V BRYAN

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: LAWLIS V BRYAN ... [Published Street Insider - May 18 2013]
First reported May 18 2013 - Updated May 18 2013 - 1 reports

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: LEWIS ALAN

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: LEWIS ALAN ... [Published Street Insider - May 18 2013]
First reported May 18 2013 - Updated May 18 2013 - 1 reports
BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: YOUNG WILLIAM D

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: YOUNG WILLIAM D ... [Published Street Insider - May 18 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: HERON ELAINE J

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: HERON ELAINE J ... [Published Street Insider - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: GREY MICHAEL G

StreetInsider.com - Form 4 BIOMARIN PHARMACEUTICAL For: May 15 Filed by: GREY MICHAEL G ... [Published Street Insider - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Stocks in Focus (Celldex Therapeutics, BioMarin Pharmaceutical Inc, Celgene Corporation, Computer Sciences Corporation)

Austin, TX -- ( SBWIRE ) -- 05/17/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-Celldex Therapeutics, ... [Published SBWire - May 17 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO

(GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that data from its ongoing Phase 1/2 trial for BMN-673 for genetically-defined cancers will be released at the American Society of Clinical Oncology (ASCO) meeting in Chicago ... [Published Benzinga.com - May 16 2013]
First reported May 14 2013 - Updated May 14 2013 - 2 reports

BioMarin Pharmaceutical (BMRN) Could Fall Through $66.53 Support Level

BioMarin Pharmaceutical (NASDAQ: BMRN) closed Monday's trading session at $68.85. In the past year, the stock has hit a 52-week low of $34.30 and 52-week high of $69.99. BioMarin Pharmaceutical (BMRN) stock has been showing support around $66.53 and resistance ... [Published Individual.com - May 14 2013]
First reported May 14 2013 - Updated May 14 2013 - 2 reports

BioMarin to Present at the UBS Global Healthcare Conference

CONTACT: Investors:Eugenia ShenBioMarin Pharmaceutical Inc.(415) 506-6570Media:Debra CharlesworthBioMarin Pharmaceutical Inc.(415) 455-7451 ... [Published Reuters - May 14 2013]

Quotes

...1/2 program at ASCO with additional data from patients in the dose expansion cohort," said Hank Fuchs, M D , Chief Medical Officer of BioMarin. "We believe that the selectivity and extreme potency of BMN-673 provide a good basis for it to potentially emerge as the best-in-class compound, and we are committed to moving forward with a Phase 3 program in gBRCA breast cancer by the end of the year."
BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO [Published Benzinga.com - May 16 2013]
...Patrick J McEnany, Catalyst's Chief Executive Officer, "Since the beginning of 2013, we have made solid progress towards completion of our 2013 corporate goals. We have completed the transfer of the Firdapse(TM) program from BioMarin and have started to add additional patients into the LMS-002 clinical trial for Firdapse(TM) to treat Lambert-Eaton Myasthenic Syndrome (LEMS). We have also made progress towards the opening of additional clinical trial sites in the U S and Europe. In that regard, we intend to regularly update the market regarding the status of our development efforts for Firdapse(TM) as these matters progress."
Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results [Published Individual.com - May 16 2013]
...heartbreak of knowing that medicines to treat their loved ones were little more than a dream," says A Maureen Rouhi, Ph D , editor-in-chief of C&EN. "As our story documents in such compelling fashion, that situation is dramatically changing. Pharmaceutical companies are making unprecedented investments in medicines for these enigmatic conditions, popularized in films, and treatments for some are on the way."
Renaissance in new drugs for rare diseases [Published Medical Xpress - May 13 2013]
...indications, as well as deep knowledge of this target for drug development," said John McKearn, managing director, RiverVest Venture Partners. "LUM001 could dramatically impact patient health for a population in desperate need of more effective treatment options, and we are glad to be a part of this potentially game-changing company."
Lumena Pharmaceuticals Announces $23 Million Series A Financing [Published FinanzNachrichten.de - May 08 2013]

More Content

All (251) | News (130) | Reports (10) | Blogs (72) | Audio/Video (5) | Fact Sheets (0) | Press Releases (33)
sort by: Date | Relevance
The Best- And Worst- Performing Biotech Stocks,... [Published Forbes.com - 6 hours ago]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 18 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 18 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 18 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 18 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 18 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 17 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 15 File... [Published Street Insider - May 17 2013]
Stocks in Focus (Celldex Therapeutics, BioMarin... [Published SBWire - May 17 2013]
BioMarin Announces BMN-673 Data in Breast and O... [Published Benzinga.com - May 16 2013]
Analysts’ Price Target Changes for May, 16th (A... [Published American Banking News - May 16 2013]
1 Biotech, 1 Financial And 1 Grocery Store With... [Published Seeking Alpha - May 16 2013]
Catalyst Pharmaceutical Partners Reports First ... [Published Individual.com - May 16 2013]
Catalyst Pharmaceutical Partners Reports First ... [Published Nasdaq - May 16 2013]
MSCI Equity Indices May 2013 Index Review [Published India Infoline - May 16 2013]
Griffin's Blue Ridge Capital Enters CBS (CBS), ... [Published Street Insider - May 16 2013]
Little hope for Little Island? [Published Irish Times - May 16 2013]
MSCI Equity Indices May 2013 Index Review [Published FinanzNachrichten.de - May 15 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 14 File... [Published Street Insider - May 15 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 12 File... [Published Street Insider - May 15 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 12 File... [Published Street Insider - May 15 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 12 File... [Published Street Insider - May 15 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 12 File... [Published Street Insider - May 14 2013]
BioMarin Pharmaceutical Inc. to Present at the ... [Published BioSpace - May 14 2013]
Form 4 BIOMARIN PHARMACEUTICAL For: May 08 File... [Published Street Insider - May 14 2013]
BioMarin Pharmaceutical (BMRN) Could Fall Throu... [Published Individual.com - May 14 2013]
BioMarin to Present at the UBS Global Healthcar... [Published Reuters - May 14 2013]
BioMarin to Present at the UBS Global Healthcar... [Published GlobeNewswire: Advertising News - May 14 2013]
BioMarin to Present at the UBS Global Healthcar... [Published Individual.com - May 14 2013]
BioMarin Pharmaceutical (BMRN) Could Fall Throu... [Published MarketIntelligenceCenter.com - May 14 2013]
1 2 3 4 5 6 7 8 9
In Focus
  •  
Jean-Jacques Bienaime, Yaron Werber, Ivan Deryugin, [more]
  •  
UBS AG, Catalyst Pharmaceutical Partners Inc, New York Stock Exchange, [more]
  •  
US Securities and Exchange Commission, European Medicines Agency, FDA Food & Drug Administration, [more]
  •  
Healthcare Conference, 8-k, Biotechnology, [more]
  •  
Firdapse, Aldurazyme, PROCYSBI, [more]
  •  
London, Washington DC, San Francisco (United States), [more]
  •  
United States, United Kingdom, Germany, [more]
  •  
Diseases, Narcotics, Medication, [more]
  •  
IT, Telecom, Banking & Financial Services, [more]
MarketIntelligenceCenter.com, Street Insider, GlobeNewswire: Acquisitions News, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioMarin Pharmaceutical (BMRN) Could Fall Throu... [Published MarketIntelligenceCenter.com - May 14 2013]
BioMarin Pharmaceutical (NASDAQ: BMRN) closed Monday's trading session at $68.85. In the past year, the stock has hit a 52-week low of $34.30 and 52-week high of $69.99. BioMarin Pharmaceutical (BMRN) stock has been showing support around $66.53 and resistance ...
R&D Spending may not be ALL Bad [Published The Big Red Biotech Blog - May 09 2013]
Fierce Biotech yesterday reported that R&D spending was up as many significant biotechs -- like Gilead, Amgen, Celgene, Shire, Regeneron, Onyx and Biomarin. In other words, many of the darlings of biotech investors -- companies who have experienced significant ...
Potential BioMarin Pharmaceutical (BMRN) Trade ... [Published MarketIntelligenceCenter.com - May 08 2013]
BioMarin Pharmaceutical (NASDAQ: BMRN) closed Tuesday's trading session at $65.41. In the past year, the stock has hit a 52-week low of $34.30 and 52-week high of $67.96. BioMarin Pharmaceutical (BMRN) stock has been showing support around $63.80 and ...
Top Wall Street Analyst Upgrades: Arch Coal, Ga... [Published 24/7 Wall St. - May 07 2013]
Investors and traders seem to be constantly looking for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many research calls each day to find great ideas... ...
Potential BioMarin Pharmaceutical (BMRN) Trade ... [Published MarketIntelligenceCenter.com - May 02 2013]
BioMarin Pharmaceutical (NASDAQ: BMRN) closed Wednesday's trading session at $63.68. In the past year, the stock has hit a 52-week low of $34.30 and 52-week high of $66.63. BioMarin Pharmaceutical (BMRN) stock has been showing support around $62.49 and ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Mad Money Uncovered: Biomarin and Alexion Orpha... [Published TheStreet.com - YouTube - Apr 02 2013]
Jean-Jacques Bienaimé, Chief Executive Officer,... [Published BIO Channel - YouTube - Feb 26 2013]
Fireside Chat With Jean-Jacques Bienaimé, Chief... [Published BIO Channel - YouTube - Feb 26 2013]
Fireside Chat With Jean-Jacques Bienaimé, Chief... [Published BIO Channel - YouTube - Feb 20 2013]
The Next Big Thing In Biotech: Ligand, BioMarin... [Published TheStreet.com - YouTube - Nov 30 2012]
1

Press Releases

sort by: Date | Relevance
BioMarin to Present at the UBS Global Healthcar... [Published GlobeNewswire: Advertising News - May 14 2013]
BioMarin to Present at the Baird Growth Stock C... [Published GlobeNewswire: Acquisitions News - May 02 2013]
BioMarin Announces First Quarter 2013 Financial... [Published GlobeNewswire: Acquisitions News - Apr 25 2013]
Bay Area High School Student Wins BioGENEius Ch... [Published Business Wire - Apr 23 2013]
BioMarin Pharmaceutical Inc. Reports Inducement... [Published GlobeNewswire: Advertising News - Apr 18 2013]
1 2 3 4 5 6 7
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.